Accueil | Epicentre

Scientific Day 2026

Discover the latest Epicentre studies.

Discover our current projects

on Ebola, COVID19, HIV, tuberculosis, malaria, Lassa fever, cholera, nutrition...

Our mission

Field epidemiology, research projects and training sessions in support of MSF.

Measles

An update on the latest studies conducted by Epicentre to combat this infectious disease
Field epidemiology activities, research projects and training sessions in support of Médecins sans frontières
Field epidemiology activities, research projects and training sessions in support of Médecins sans frontières

Latest news

Latest publications

Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.

Lancet (London, England) 2026 Jan 13; . doi: 10.1016/S0140-6736(25)02069-0. Epub 2026 01 13
Published on

Community and hospital-acquired invasive bacterial infections in hospitalised patients with advanced HIV disease: a prospective study in Kinshasa, DRC.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2026 Jan 10; . doi: 10.1016/j.ijid.2026.108383. Epub 2026 01 10
Published on

Health-economic impacts of age-targeted and sex-targeted Lassa fever vaccination in endemic regions of Nigeria, Guinea, Liberia, and Sierra Leone: a modelling study.

The Lancet. Global health 2026 Feb ; 14(2); . doi: 10.1016/S2214-109X(25)00450-4. Epub 2026 01 10
Published on

Trends in Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine and amodiaquine over ten years of seasonal malaria chemoprevention in Moissala Health District, Chad.

Malaria journal 2025 Dec 31; . doi: 10.1186/s12936-025-05771-2. Epub 2025 12 31
Published on

Discover our training courses

Transmitting and transferring epidemiological knowledge is an integral part of Epicentre's mission. Training courses are provided throughout the year to MSF staff and beyond.